Omnicell, Inc.
NASDAQOmnicell just delivered its strongest quarter in years — and the market wasted no time responding. Q1 adjusted EPS of $0.55 nearly doubled the $0.32 consensus estimate. Revenue of $309.9M beat the $304M forecast. The company followed with a full-year EPS guidance raise to $1.80–$2.00, well above the $1.75 Street estimate, while affirming its sales outlook of $1.215B–$1.255B. The…
Snapshot as of 9 May 2026
Omnicell just delivered its strongest quarter in years — and the market wasted no time responding. Q1 adjusted EPS of $0.55 nearly doubled the $0.32 consensus estimate. Revenue of $309.9M beat the $304M forecast. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OMCL — free to start on ORTEX.
Sign up for free →Open OMCL on ORTEX